Departamento de anestesiología, Fundación Valle del Lili, Cra 98 No. 18-49, Cali, 760032, Colombia.
Centro de investigaciones clínicas, Fundación Valle del Lili, Cra 98 No. 18-49, Cali, 760032, Colombia.
BMC Anesthesiol. 2023 Dec 18;23(1):415. doi: 10.1186/s12871-023-02370-z.
Intraoperative pulmonary embolism (PE) with cardiac arrest (CA) represents a critical and potentially fatal condition. Available treatments include systemic thrombolysis, catheter-based thrombus fragmentation or aspiration, and surgical embolectomy. However, limited studies are focused on the optimal treatment choice for this critical condition. We present a case series and an updated review of the management of intraoperative CA secondary to PE.
A retrospective review of patients who developed high-risk intraoperative PE was performed between June 2012 and June 2022. For the updated review, a literature search on PubMed and Scopus was conducted which resulted in the inclusion of a total of 46 articles.
A total of 196 174 major non-cardiac surgeries were performed between 2012 and 2022. Eight cases of intraoperative CA secondary to high-risk PE were identified. We found a mortality rate of 75%. Anticoagulation therapy was administered to one patient (12.5%), while two patients (25%) underwent thrombolysis, and one case (12.5%) underwent mechanical thrombectomy combined with thrombus aspiration. Based on the literature review and our 10-year experience, we propose an algorithm for the management of intraoperative CA caused by PE.
The essential components for adequate management of intraoperative PE with CA include hemodynamic support, cardiopulmonary resuscitation, and the implementation of a primary perfusion intervention. The prompt identification of the criteria for each specific treatment modality, guided by the individual patient's characteristics, is necessary for an optimal approach.
术中肺栓塞(PE)伴心脏骤停(CA)是一种严重且潜在致命的情况。现有的治疗方法包括全身溶栓、基于导管的血栓碎裂或抽吸以及外科取栓。然而,针对这种危急情况,目前仅有有限的研究关注于最佳治疗选择。我们报告了一系列病例,并对术中 PE 导致 CA 的治疗管理进行了更新综述。
回顾性分析了 2012 年 6 月至 2022 年 6 月期间发生高危术中 PE 的患者。为了进行更新综述,我们在 PubMed 和 Scopus 上进行了文献检索,共纳入了 46 篇文章。
2012 年至 2022 年间共进行了 196174 例非心脏大手术。发现 8 例术中 CA 继发于高危 PE。我们发现死亡率为 75%。1 例(12.5%)患者接受了抗凝治疗,2 例(25%)患者接受了溶栓治疗,1 例(12.5%)患者接受了机械血栓切除术联合血栓抽吸。基于文献回顾和我们 10 年的经验,我们提出了一种针对术中 PE 伴 CA 的管理算法。
充分管理术中 PE 伴 CA 的关键要素包括血流动力学支持、心肺复苏以及实施主要灌注干预。根据个体患者的特点,及时识别每种特定治疗方法的标准,对于优化治疗方法至关重要。